Yervoy (ipilimumab) is a medication used to treat melanoma, a type of skin cancer. The criteria for Yervoy discount are not mentioned in the sources provided. However, the sources provide information about the drug's patent status, its FDA-approved uses, and its potential side effects.
According to Drug Patent Watch [1], Yervoy is a biologic drug that was first approved by the FDA in 2011. The drug's patent is set to expire in 2023, which means that generic versions of the drug may become available after that date. The website provides information about the drug's patent status, including its expiration date, which can be useful for those interested in the drug's availability and pricing.
The FDA-approved label for Yervoy [2] provides information about the drug's approved uses, dosage, and administration. The label states that Yervoy is indicated for the treatment of unresectable or metastatic melanoma in adults and pediatric patients who are 12 years of age and older. The label also provides information about the drug's potential side effects, including immune-mediated adverse reactions that can affect the skin, gastrointestinal system, liver, and endocrine system.
The package insert for Yervoy [3] provides additional information about the drug's mechanism of action, clinical pharmacology, and dosing recommendations. The insert also provides information about the drug's potential side effects, including serious immune-mediated adverse reactions that can be life-threatening if not promptly identified and treated.
In summary, the sources provided do not mention the criteria for Yervoy discount. However, they provide useful information about the drug's patent status, FDA-approved uses, and potential side effects. It is important to consult with a healthcare provider for personalized information about the drug's benefits and risks, as well as its cost and availability.
Sources:
[1] https://www.drugpatentwatch.com/p/biologics/tradename/YERVOY
[2] https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125377s110lbl.pdf
[3] https://packageinserts.bms.com/pi/pi_yervoy.pdf